ASTM E1174: Healthcare Handwash Efficacy Testing Services

Scope

ASTM E1174 establishes procedures to assess the effectiveness of healthcare handwash formulations by measuring microbial reduction on human hands after artificial contamination and washing. It ensures controlled testing conditions for reliable and repeatable results.

• ASTM E1174 lays out a standardized in vivo procedure for evaluating antimicrobial handwash and antiseptic formulations meant for routine use by healthcare personnel.
• It applies to products marketed for frequent hand hygiene in clinical settings – not to surgical scrub products, which fall under separate standards.
• Human subjects are the test vehicle here. Their hands get experimentally contaminated with a defined, non-pathogenic marker organism to simulate transient microbial flora.
• Recovery relies on the “glove juice” sampling technique, used to pull bacteria off the hand surface both before and after product use.
• Converting bacterial recovery counts into log10 reduction values is how the data ends up expressing just how effectively a product lowered the contaminating population.
• Depending on study design, the standard can assess an immediate reduction after a single wash, a sustained or cumulative effect across repeated washes over multiple days, or both.
• ASTM Subcommittee E35.15 on Antimicrobial Agents maintains E1174; the current active edition dates to 2021, with earlier versions issued in 2000, 2006, and 2013.
• Controlled inoculation with a marker organism is what sets this method apart methodologically from standards that rely on a subject’s natural resident flora.
• Regulatory submissions reference the test often, including those supporting FDA review of healthcare personnel handwash and antiseptic products.
• Results get statistically evaluated across a representative subject panel – not pulled from a single demonstration wash.

Applications

• Antimicrobial handwash, antiseptic soap, and sanitizing cleanser formulations marketed to nurses, physicians, and other clinical staff.
• Healthcare facility hand hygiene products going through efficacy substantiation before a market launch or a label claim update.
• FDA OTC healthcare antiseptic submissions that need standardized clinical efficacy data.
• Reformulation work – comparing a revised formula against a prior version, or against a competitor’s benchmark.
• Hospital and institutional procurement evaluations, where buyers want independent efficacy verification before they’ll adopt a product.
• R&D programs screening new active ingredients or surfactant systems for clinical hand hygiene use.
• Quality and regulatory affairs teams assembling a defensible data package alongside stability, safety, and skin compatibility studies.

Benefits

• Clinically relevant, human-subject efficacy data – not just in vitro or surrogate-surface results.
• Backs regulatory submissions with a method FDA reviewers already recognize for healthcare personnel handwash products.
• Sets a formulation’s real-world performance apart from competitors’ through standardized, comparable log reduction data.
• Helps manufacturers confirm both the immediate and the sustained antimicrobial benefit of a product across a realistic use pattern.
• Produces documentation that supports marketing and label claims with traceable, reproducible test evidence.
• Builds confidence among healthcare purchasers that a product does what it’s supposed to under actual hand hygiene conditions.